GLP-1 medications have quickly taken center stage when it comes to talking about obesity care. As demand grows, employers now have to navigate complex decisions around access, cost, and long-term sustainability, often with increasing financial and regulatory demands.
As coverage conversations continue to amp up the pressure, it’s easy to default to a focus only on medication use alone. That narrow focus can disregard a critical truth: obesity is a chronic condition that requires ongoing, whole-person care – not one single intervention.
Access to GLP-1’s alone doesn’t solve the hardest problems for employers: sustainable cost structures, employee engagement, and long-term outcomes.
GLP-1s are in the spotlight and employer pressure is rising
GLP-1 therapies now account for more than 20% of pharmacy spend in some employer plans, according to a multi-year study of U.S. commercial health claims data. At the same time, employers are projecting an average ~9% increase in total healthcare costs for 2026, with pharmacy costs (particularly GLP-1s) outpacing the larger medical market trend.
These new facts are making conversations around sustainability even more urgent.
Benefits leaders are asking practical questions like:
- How can plans balance access with affordability?
- What does long-term use look like across diverse populations?
- How can outcomes be sustained beyond initial weight loss?
With no federal mandate requiring obesity coverage, but growing litigation and state-level activity, many organizations feel pressure to move quickly.
The intent is clear: support employees. The uncertainty lies in how to do so sustainably.
Why medication alone isn’t enough
Don’t get us wrong: GLP-1s play an important role in obesity care. But when treatment strategies rely solely on quick fixes, long-term outcomes often fall short.
Without addressing the behaviors, environments, and emotional factors that influence weight and health, employee engagement in health programs can wane over time. Plateaus happen. Life intervenes. And without broader support, progress can be difficult to sustain, especially if medication use changes or stops.
That’s why leading organizations are beginning to look beyond medication-only models toward integrated obesity management.
What integrated obesity management means in practice
Some employees use GLP-1s through employer coverage. Some may pursue self-pay options. Many may never use medication at all. Integrated obesity management is about supporting all of those paths within a single, coherent strategy that brings together:
- Appropriate clinical guidance and medication management, including GLP-1s when necessary
- Behavior change support across all factors that contribute to a healthy weight: nutrition, movement, sleep, stress, and mental well-being
- Digital programs with real human engagement that helps people build sustainable habits over time
- Data and measurement to track engagement, outcomes, and overall impact
When GLP-1 therapy is embedded in a holistic health system, it becomes part of a broader strategy, one designed to support people for the long term, not just their first few months.
The results tend to be steadier engagement, more predictable utilization, and fewer surprises as programs scale.
Why this matters to employers in 2026
Employer priorities are shifting. Recent surveys show that healthcare cost containment has become the #1 strategic focus for 2026, surpassing even talent recruitment.
At the same time, employee expectations are also changing to include:
- Growing interest in preventive health and weight management
- Demand for more personalized, holistic benefits
- A desire for support that feels empathetic, not transactional or strictly metrics-driven
Integrated obesity management addresses both realities. It helps employers:
- Support employee well-being beyond a prescription
- Improve long-term outcomes across their population
- Use medications more strategically and responsibly
- Reduce downstream risks and total cost of care
Integrative care creates more room for employers to make thoughtful decisions about access, guardrails, and how benefits can evolve over time.
Approaches like this are already showing great results.
In a recent case study, a large employer paired structured weight management with targeted GLP-1 access. With a holistic approach, they achieved sustained engagement well above benchmarks, 5–10% weight loss among their participants, and $2.8M in projected savings.
Rethinking obesity care moving forward
The effectiveness of GLP-1s is undeniable and will continue to play a vital role in obesity care. But the most effective strategies have a plan for overall health beyond medication.
The question for employers isn’t simply whether to cover GLP-1s. It’s how to integrate them effectively into a long-term obesity management strategy that supports behavior change, employee well-being, and population health at scale.
At Wondr Health, we believe obesity care works best when it reflects how people actually live. That means meeting people where they are and combining behavioral science, preventive support, and configurable medication strategies to deliver better outcomes.
Why Wondr Health
Wondr Health is the trusted leader in preventive weight and GLP‑1 management solutions. Building on the strength of our digital behavioral program, Wondr Health delivers smarter weight management benefits with configurable GLP‑1 coverage strategies that give employers and health plans more choice and maximum cost control. Integrated coaching, condition-specific care tracks, nutrition support, and connected devices drive sustained behavior change to prevent chronic disease and avoid downstream spend. Backed by 20 years of experience in the benefits space, Wondr Health sets a new standard for accessible, affordable care—helping organizations future-proof their weight management strategy while empowering individuals to live healthier, happier lives.
If you’re rethinking your obesity benefits approach, our team is ready to explore what an integrated strategy could look like for your workforce.
